The cancer-derived Transforming Growth Factor-β (TGF-β) in PDAC patients plays an important role in converting normal fibroblasts into myofibroblastic CAFs (54), which produce αSMA, and fibroblast activation protein (FAP) (55). Here, ACTA1 is linked to cancer.